Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26 21:42 | 4/13/26 | MLYS | Health | Drug | Pharmaceutical Preparations | Rodman David Malcom | PA | O | Chief Me | 16 | M.dm | 2,328 | 19.58 | 0 | 119 | 82 | D | |||||||||||||||
5/13/26 21:42 | 4/13/26 | MLYS | Health | Drug | Pharmaceutical Preparations | Rodman David Malcom | PA | O | Chief Me | 16 | S.dm | -2,328 | 19.58 | 0 | -119 | 82 | D | |||||||||||||||
4/15/26 21:45 | 4/13/26 | MLYS | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | 2 | S | -2,393 | 26.37 | 0 | -91 | 705 | D | |||||||||||||||
4/2/26 18:53 | 3/31/26 | MLYS | Health | Drug | Pharmaceutical Preparations | Karydas Daphne | PA | D | 2 | M.d | 111 | 18.51 | 0 | 6 | 999% | 6 | D | |||||||||||||||
4/2/26 18:53 | 3/31/26 | MLYS | Health | Drug | Pharmaceutical Preparations | Karydas Daphne | PA | D | 2 | S.d | -111 | 18.51 | 0 | -6 | 6 | D | ||||||||||||||||
3/31/26 16:15 | 3/27/26 | MLYS | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | D | 1 | P.m | 8,763 | 23.75 | 0 | 369 | 5 | 7,693 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |